This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks With Huge Insider Buying


Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

A stock in the biotechnology and drugs complex that insiders are snapping up is MannKind (MNKD), which is focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. Insiders are buying this stock into some modest strength, since shares are up about 5% so far in 2012.

MannKind has a market cap of $414.5 million and an enterprise value of $852 million. Its estimated growth rate for this year is 26.5%, and for next year it's pegged at 52.6%. This is not a cash-rich company, since the total cash position on its balance sheet is $56.71 million, and its total debt is $494.40 million.

The CEO and chairman of the board just bought 31,250,000 shares, or about $77.18 million worth of stock, at $2.47 per share.

>>5 Health Care Stocks Setting Up to Break Out

From a technical perspective, MNKD is currently trading above both its 50-day and 200-day moving averages, which is bullish. This stock bottomed back in June after buying interest came in at around $1.65 to $1.70 a share. Following that bottom, shares of MNKD rallied hard to its recent high of $2.91 a share. During that rally, shares of MNKD were making higher lows and higher highs, which is bullish technical price action.

If you're in the bull camp on MNKD, then I would look for long-biased trades as long as this stock is trending above its 200-day moving average of $2.55 with strong upside volume flows. Look for volume that's tracking in close to or above its three-month average action of 2 million shares. If MNKD can manage to hold that trend, then this stock has a great chance of trading back towards its next significant overhead resistance level at $3.48 a share.

On the flipside, I would avoid MNKD if it moves back below its 200-day at $2.55 with high-volume. If this stock were to take out its 200-day with volume, then we could get a re-test of its 50-day moving average of $2.01 a share.
3 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
DAKT $8.70 0.00%
MNKD $1.35 0.00%
SNTA $0.40 0.00%
WPRT $2.46 0.00%
AAPL $93.74 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs